Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DEGARELIX for Prostatic specific antigen increased: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 13 adverse event reports in the FDA FAERS database where DEGARELIX was used for Prostatic specific antigen increased.

Most Reported Side Effects for DEGARELIX

Side Effect Reports % Deaths Hosp.
Injection site pain 296 7.8% 13 52
Injection site erythema 246 6.5% 6 46
Hot flush 199 5.3% 2 28
Fatigue 195 5.2% 6 61
Injection site swelling 183 4.8% 3 25
Product storage error 177 4.7% 0 0
Pyrexia 170 4.5% 8 96
Off label use 128 3.4% 16 35
Asthenia 123 3.3% 11 47
Death 120 3.2% 116 33
Injection site mass 118 3.1% 2 11
Malaise 117 3.1% 9 65
Fall 113 3.0% 9 80
Prostatic specific antigen increased 111 2.9% 9 26
Interstitial lung disease 109 2.9% 16 72

Other Indications for DEGARELIX

Prostate cancer (2,035) Product used for unknown indication (1,046) Prostate cancer metastatic (237) Hormone-dependent prostate cancer (187) Hormone-refractory prostate cancer (102) Neoplasm malignant (19) Bone cancer (11) Metastases to bone (11) Prostate cancer stage iv (8) Hormone therapy (7)

Other Drugs Used for Prostatic specific antigen increased

ENZALUTAMIDE (199) LEUPROLIDE (64) ABIRATERONE (40) BICALUTAMIDE (25) FINASTERIDE (21) RELUGOLIX (15) DENOSUMAB (14) TAMSULOSIN (12) APALUTAMIDE (11) CIPROFLOXACIN (11)

Related Pages

DEGARELIX Full Profile All Prostatic specific antigen increased Drugs DEGARELIX Demographics DEGARELIX Timeline